Catálogo
Ayuda
Construye tu portafolio aquí
Ingresa la cantidad junto a las acciones que necesitas — el portafolio se creará automáticamente.
Filtro rápido: categorías, recomendaciones, métricas fundamentales y perfiles de empresas.
Paquete inicial de dividendos
Blue chips — comprar
Líderes de crecimiento
Defensivas — baja volatilidad
| Empresa | Categoría | Precio | Δ% | Div% | Vol20 | EPS(TTM) | QoQ | EPS(SPR) | Estilo | Horizonte | Pot. | Riesgo | Recomendación | Portafolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abivax (ABVX) | Biotecnología | 125.70 | -4.16% | 0.0% | 8.8% | -5.84 | -200.0% | 24.8% | Crecimiento | Medio | 39 | 76 | Vender |
|
| Alnylam Pharmaceuticals (ALNY) | Biotecnología | 271.77 | +1.13% | 0.0% | 2.3% | 4.36 | 6.4% | 73.2% | Crecimiento | Medio | 57 | 70 | Mantener |
|
| Apogee Therapeutics (APGE) | Biotecnología | 134.28 | +0.01% | 0.0% | 0.1% | -4.33 | 0.0% | 0.0% | Crecimiento | Largo | 46 | 70 | Vender |
|
| Arrowhead Pharmaceuticals (ARWR) | Biotecnología | 85.60 | -1.36% | 0.0% | 3.1% | -2.14 | -72.1% | 21.2% | Crecimiento | Medio | 72 | 65 | Comprar |
|
| Bio-Techne (TECH) | Biotecnología | 71.60 | -0.24% | 0.4% | 0.3% | 0.71 | 5.3% | -3.6% | Crecimiento | Medio | 54 | 45 | Mantener |
|
| Biohaven (BHVN) | Biotecnología | 14.32 | -2.25% | 0.0% | 3.8% | -5.67 | 0.0% | -2.3% | Crecimiento | Medio | 42 | 74 | Vender |
|
| BioNTech (BNTX) | Biotecnología | 89.33 | -2.97% | 0.0% | 1.5% | -5.09 | -86.6% | 3.7% | Crecimiento | Medio | 24 | 85 | Vender |
|
| Celcuity (CELC) | Biotecnología | 82.62 | -6.47% | 0.0% | 5.2% | -3.89 | 0.0% | 6.7% | Crecimiento | Medio | 25 | 84 | Vender |
|
| Centessa Pharmaceuticals (CNTA) | Farmacéutica | 40.50 | 0.00% | 93.8% | 0.0% | -1.78 | 0.0% | -36.8% | Crecimiento | Medio | 30 | 70 | Vender |
|
| Cidara Therapeutics (CDTX) | Biotecnología | 221.38 | 0.00% | 0.0% | 0.0% | -11.78 | 0.0% | 0.0% | Crecimiento | Medio | 30 | 80 | Vender |
|
| Corcept Therapeutics (CORT) | Biotecnología | 95.36 | -1.34% | 0.0% | 2.4% | 0.45 | -18.4% | -111.3% | Crecimiento | Medio | 57 | 70 | Mantener |
|
| Corvus Pharmaceuticals (CRVS) | Biotecnología | 13.07 | -4.46% | 0.0% | 3.0% | -0.55 | 0.0% | -7.1% | Crecimiento | Medio | 20 | 80 | Vender |
|
| CPRX (CPRX) | Salud | 31.49 | 0.00% | 0.0% | 0.0% | 1.80 | -2.1% | 15.6% | Crecimiento | Medio | 62 | 40 | Comprar |
|
| Crinetics Pharmaceuticals (CRNX) | Biotecnología | 83.73 | +0.10% | 0.0% | 21.4% | -5.14 | 74.2% | 0.0% | Crecimiento | Medio | 70 | 60 | Mantener |
|
| Definium Therapeutics (DFTX) | Biotecnología | 43.17 | +0.56% | 0.0% | 3.6% | -2.50 | 0.0% | -44.3% | Crecimiento | Medio | 41 | 67 | Vender |
|
| Disc Medicine (IRON) | Biotecnología | 74.12 | -2.29% | 0.0% | 2.0% | -6.64 | 0.0% | -1.7% | Crecimiento | Medio | 31 | 70 | Vender |
|
| ImmunityBio (IBIO) | Biotecnología | 1.43 | +2.14% | 0.0% | 2.3% | -0.58 | -100.0% | -16.7% | Crecimiento | Medio | 20 | 80 | Vender |
|
| Immunovant (IMVT) | Biotecnología | 39.41 | +0.10% | 0.0% | 1.8% | -2.78 | 0.0% | -23.3% | Crecimiento | Medio | 40 | 70 | Vender |
|
| Incyte (INCY) | Farmacéutica | 117.67 | +0.84% | 0.0% | 1.2% | 7.30 | -15.5% | 31.2% | Crecimiento | Medio | 69 | 41 | Comprar |
|
| Intellia Therapeutics (NTLA) | Biotecnología | 10.73 | -3.33% | 0.0% | 3.8% | -3.54 | -34.6% | 12.0% | Crecimiento | Medio | 25 | 80 | Vender |
|
| Kymera Therapeutics (KYMR) | Biotecnología | 110.57 | +0.17% | 0.0% | 2.7% | -3.58 | 1101.6% | 0.0% | Crecimiento | Largo | 68 | 69 | Mantener |
|
| Ligand Pharmaceuticals (LGND) | Farmacéutica | 300.53 | -0.54% | 0.0% | 1.8% | 7.84 | -13.3% | -11.4% | Crecimiento | Medio | 45 | 70 | Vender |
|
| MGX (MGX) | Salud | 1.21 | -1.23% | 0.0% | 2.3% | -2.30 | -68.1% | 0.0% | Valor | Largo | 20 | 85 | Vender |
|
| Moderna (MRNA) | Farmacéutica | 54.07 | -5.17% | 0.0% | 4.4% | -8.15 | -42.6% | 60.9% | Crecimiento | Medio | 39 | 76 | Vender |
|
| Ovid Therapeutics (OVID) | Biotecnología | 2.33 | -2.92% | 0.0% | 3.1% | -0.35 | -100.0% | 0.0% | Crecimiento | Medio | 30 | 80 | Vender |
|
| Regeneron Pharmaceuticals (REGN) | Biotecnología | 656.01 | +0.63% | 0.5% | 1.8% | 42.53 | -7.2% | 6.3% | Crecimiento | Largo | 55 | 66 | Mantener |
|
| Regenxbio (RGNX) | Biotecnología | 9.73 | -5.07% | 0.0% | 5.4% | -5.60 | -78.9% | -26.5% | Crecimiento | Corto | 25 | 80 | Vender |
|
| Revolution Medicines (RVMD) | Farmacéutica | 189.23 | +0.25% | 0.0% | 1.7% | -7.11 | 0.0% | -25.1% | Crecimiento | Medio | 42 | 70 | Vender |
|
| Sarepta Therapeutics (SRPT) | Biotecnología | 15.68 | -1.26% | 0.0% | 2.8% | 0.62 | 65.0% | 223.8% | Crecimiento | Medio | 33 | 75 | Vender |
|
| Scholar Rock (SRRK) | Biotecnología | 47.67 | -3.66% | 0.0% | 2.6% | -3.45 | 0.0% | -1.2% | Crecimiento | Medio | 30 | 72 | Vender |
|